Determination of the optimal surgical procedure by identifying risk factors for pneumonia after transthoracic esophagectomy
- 26 Downloads
Esophagectomy is associated with a high risk of postoperative complications, and the respiratory complications are the most common. Therefore, stratification of patients based on preoperative risk factors is essential. This study aimed to identify the risk of postoperative pneumonia (POP) based on the preoperative factors and determine the optimal perioperative surgical management strategy.
This retrospective study involved 207 patients who underwent esophagectomy. The patients were divided into two groups, namely, with POP and without POP. To identify the risk factors for POP, the pre- and perioperative characteristics were analyzed. A receiver operating characteristics curve was used to determine a cutoff value of 2.40 L for the forced expiratory volume in 1 s (FEV1.0) and the cohort was divided into a high- and low-FEV1.0 group. A second analysis was then performed to determine the optimal surgical management for patients at a high risk for POP.
POP occurred in 45 (21.7%) patients. A multiple logistic regression analysis showed that FEV1.0 was significantly lower in the POP (+) group (P = 0.020); thus, a low FEV1.0 was found to be a risk factor for POP. Multiple logistic regression analysis showed that open thoracotomy was a significant risk factor for POP in low FEV1.0 patients (P = 0.013).
A low FEV1.0 and an open thoracotomy are risk factors for POP. Therefore, patients with low FEV1.0 should be managed carefully and video-assisted thoracic surgery should be considered.
KeywordsEsophagectomy Esophageal neoplasm Pneumonia
The authors thank Kumiko Motooka, who belongs to the staff at Keio University School of Medicine, for her help in the preparation of this report.
Compliance with ethical standards
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.
Conflict of interest
Author Masato Hayashi, Corresponding Author Hiroya Takeuchi, Author Rieko Nakamura, Author Koichi Suda, Author Norihito Wada, Author Hirofumi Kawakubo, and Author Yuko Kitagawa declare that they have no conflict of interest.
- 6.Liedman BL, Bennegård K, Olbe LC, Lundell LR. Predictors of postoperative morbidity and mortality after surgery for gastro-oesophageal carcinomas. Eur J Surg. 1995;161:173–80.Google Scholar
- 9.Hayashi M, Kawakubo H, Shoji Y, Mayanagi S, Nakamura R, Suda K, et al. Analysis of the effect of early versus conventional nasogastric tube removal on postoperative complications after transthoracic esophagectomy: a single-center, randomized controlled trial. World J Surg. 2019;43:580–9. https://doi.org/10.1007/s00268-018-4825-1.CrossRefGoogle Scholar
- 14.Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRefGoogle Scholar
- 16.Nozaki I, Mizusawa J, Kato K, Igaki H, Ito Y, Daiko H, et al. Impact of laparoscopy on the prevention of pulmonary complications after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter study. Surg Endosc. 2017;4:1–9.Google Scholar
- 17.Shiozaki A, Fujiwara H, Okamura H, Murayama Y, Komatsu S, Kuriu Y, et al. Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett. 2012;4:907–12.Google Scholar
- 23.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.org. Accessed 8 Sept 2019.
- 24.Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(3):324–30.Google Scholar
- 25.Masuko H, Sakamoto T, Kaneko Y, Iijima H, Naito T, Noguchi E, et al. Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes. Int J Chron Obstruct Pulm Dis. 2011;6:181–9. https://doi.org/10.2147/COPD.S16383 Epub 2011 Mar 2.Google Scholar